Celanese corp director Ganesh Moorthy buys $54,670 in stock

Published 10/03/2025, 22:16
Celanese corp director Ganesh Moorthy buys $54,670 in stock

Ganesh Moorthy, a director at Celanese Corp (NYSE:CE), recently acquired 1,000 shares of the company’s common stock, amounting to a total purchase value of $54,670. The shares were bought at a price of $54.67 each, according to a recent SEC filing. The purchase comes as the stock has declined over 63% in the past year, though it has shown recent strength with a 17% gain in the past week. This transaction increases Moorthy’s indirect ownership of Celanese shares, held through the Ganesh and Hema Moorthy Revocable Living Trust, to 2,000 shares. The purchase reflects Moorthy’s continued investment in the company, which is known for its production of plastic materials and synthetic resins. According to InvestingPro analysis, Celanese appears slightly undervalued at current levels, with analysts projecting a return to profitability this year. For deeper insights into CE’s valuation and growth prospects, investors can access the comprehensive Pro Research Report, available exclusively on InvestingPro.

In other recent news, Celanese Corporation has announced the issuance of senior notes totaling $1.8 billion. The offering includes $700 million in 6.500% Senior Notes due 2030 and $1.1 billion in 6.750% Senior Notes due 2033, alongside €750 million in 5.000% Senior Notes due 2031. This strategic move aims to bolster Celanese’s financial position and support its business operations. Meanwhile, Piper Sandler has adjusted its outlook on Celanese, setting a new price target at $50, down from $77, while maintaining an Underweight rating. The firm has significantly reduced its EBITDA estimates for 2025 and 2026, citing challenges the company may face in financial recovery.

BofA Securities also revised its price target for Celanese, lowering it from $88 to $72 but maintaining a Buy rating. The analysts anticipate an improvement in EBITDA beyond the initial quarters of 2025, despite recent underwhelming earnings reports. UBS has decreased its price target for Celanese to $60 from $72, maintaining a Neutral rating. The firm noted that the company is facing additional one-time items affecting earnings, with EPS estimates for 2025 and 2026 significantly reduced.

RBC Capital Markets has downgraded Celanese’s stock rating from Outperform to Sector Perform, reducing the price target to $56 from $84. The downgrade was influenced by concerns over Celanese’s exposure to the automotive market, particularly in Europe. These developments are being closely monitored by investors as they evaluate Celanese’s financial performance and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.